Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Covington
Farmers Insurance
Chinese Patent Office
Cerilliant
US Army
Colorcon
US Department of Justice
Queensland Health

Generated: October 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,866,584

« Back to Dashboard

Summary for Patent: 5,866,584

Title: Therapeutic process for the treatment of the pathologies of type II diabetes
Abstract:A process for the long term modification and regulation of lipid and carbohydrate metabolism--generally to reduce obesity, insulin resistance, and hyperinsulinemia or hyperglycemia, or both (these are the hallmarks of noninsulin dependent, or Type II diabetes)--by administration (i.e., by oral, sublingual or parenternal administration) to a vertebrate, animal or human, of a dopamine agonist, e.g., bromocriptine. Administration of the bromocriptine is made over a limited period at a time of day dependent on the normal circadian rhythm of insulin resistant and insulin sensitive members of a similar species. Insulin resistance, and hyperinsulinemia and hyperglycemia, or both, can be controlled in humans on a long term basis by such treatment inasmuch as the short term, daily administration resets hormonal timing in the neural centers of the brain to produce long term effects.
Inventor(s): Cincotta; Anthony H. (Andover, MA), Meier; Albert H. (Baton Rouge, LA)
Assignee: The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College (Baton Rouge, LA)
Application Number:08/465,818
Patent Claim Types:
see list of patent claims
Use; Process; Delivery; Compound;

No matches for this query

International Patent Family for Patent: 5,866,584

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria174793► Subscribe
Austria227566► Subscribe
Austria249216► Subscribe
Austria290863► Subscribe
Austria391506► Subscribe
Austria440606► Subscribe
Australia670752► Subscribe
Australia687034► Subscribe
Australia3147995► Subscribe
Australia702392► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Fish and Richardson
Cerilliant
Merck
Healthtrust
QuintilesIMS
Moodys
Chinese Patent Office
Cantor Fitzgerald
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot